AgarJ. F., GoldsteinF. W., GerbaudG. R., ChabbertY. A.1977; Trimethoprim resistance plasmids: transferability and incompatibility groups. Annales de l’Institute Lille 128A:41–47 in French with English abstract
Am yesS. G. B., EmmersonA. M., SmithJ. T.1978; R-factor mediated trimethoprim resistance: result of two three-month clinical surveys. Journal of Clinical Pathology 31:850–854
AmyesS. G. B., SmithJ. T.1974; R-factor trimethoprim resistance mechanism; an insusceptible target site. Biochemical and Biophysical Research Communications 58:412–418
AmyesS. G. B., SmithJ. T.1976; The purification and properties of the trimethoprim-resistant dihydrofolate reductase mediated by the R-factor, R388. European Journal of Biochemistry 61:597–603
AndersonJ. D.1975; Factors that may prevent transfer of antibiotic resistance between gram-negative bacteria in the gut. Journal of Medical Microbiology 8:83–88
AndersonJ. D., GillespieW. A., RichmondM. H.1973; Chemotherapy and antibiotic resistance transfer between enterobacteria in the human gastro-intestinal tract. Journal of Medical Microbiology 6:461–473
AndersonJ. D., LaceyR. W., LewisE. L., SellinM. A.1974; Failure to demonstrate an advantage in combining sulphamethoxazole with trimethoprim in an experimental model of urinary infection. Journal of Clinical Pathology 27:619–622
BaileyR. R., BlakeE.1980; Treatment of uncomplicated urinary tract infections with a single dose of co-trimoxazole. New Zealand Medical Journal 92:285–286
BarkerJ., HealingD., HutchisonJ. G. P.1972; Characteristics of some co-trimoxazole-resistant Enterobacteriaceae from infected patients. Journal of Clinical Pathology 25:1086–1088
BarthP. T., DattaN., HedgesR. W., GrinterN. J.1976; Transposition of a deoxyribonucleic acid sequence encoding trimethoprim and streptomycin resistance from R483 to other replicons. Journal of Bacteriology 125:800–810
BennettP. M., RichmondM. H.1976; The transposition of a discrete piece of deoxyribonucleic acid carrying an amp gene between replicons in Escherichia coli. Journal of Bacteriology 126:1–6
BrodaP.1979 Molecular relationships between plasmids. Plasmids of medical, environmental and commercial importance edited by TimmisK., PiihlerA. Elsevier; North Holland:23
BrumfittW., PursellR.1972; Double-blind trial to compare ampicillin, cephalexin, co-trimoxazole and trimethoprim in treatment of urinary infection. British Medical Journal 2:673–676
BurchallJ. J.1970 Purification and properties of dihydrofolate reductase from Escherichia coli. Chemistry and biology of pteridines edited by IwaiK. et al. International Academic Printing; Tokyo:351–355
ByfordA.1979; The use of a centrifugal analyser to study the effect of inhibitors on the dihydrofolate reductase. FIMLS Thesis Institute of Medical Laboratory Sciences; London:
ChopraI.1976; Mechanism of tetracycline and fusidic acid resistance in Staphylococcus aureus. Staphylococci and staphylococcal diseases3rd International SymposiumWarsaw edited by JeljaszewiczJ. Gustav Fisher Verlag; Stuttgart:287
DattaN., HughesV. M., NugentM. E., RichardsH.1979; Plasmids and transposons and their stability and mutability in bacteria isolated during an outbreak of hospital infection. Plasmid 2:182–196
EvansR. J., WaterworthP. M.1966; Naturally-occurring fusidic acid resistance in staphylococci and its linkage to other resistance. Journal of Clinical Pathology 19:355–360
FeroneR., BushbyS. R. M, BurchallJ. J., MooreW. D., SmithD.1975; Identification of Harper-Cawston factor as thymidine Phosphorylase and removal from media of substances interfering with susceptibility testing to sulfonamides and diamino-pyrimidines. Antimicrobial Agents and Chemotherapy 7:91–98
FruensgaardK., KörnerB.1974; Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections. Chemotherapy 20:97–101
GleckmanR. A.1973; A cooperative controlled study of the use of trimethoprim-sulpha-methoxazole in chronic urinary tract infections. Journal of Infectious Diseases 128:suppl.647–651
GoldeD. W., BerschN., QuanS. G.1978; Trimethoprim and sulphamethoxazole inhibition of haematopoiesis in vitro. British Journal of Haematology 40:363–367
GoraiA. P., HeffronF., FalkowS., HedgesR. W., DattaN.1979; Electron microscope heteroduplex studies of sequence relationships among plasmids of the W incompatibility group. Plasmid 2:485–492
GreenwoodD.1979; Relevance of in vitro synergy to therapy; does synergy between diaminopyrimidines and sulphonamides operate at concentrations achievable in urine?. Journal of Antimicrobial Chemotherapy 5:suppl. B85–89
GreenwoodD., O’GradyF.1976; Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli. Journal of Clinical Pathology 29:162–166
GreyD., Hamilton-MillerJ. M. T., BrumfittW.1979; Incidence and mechanisms of resistance to trimethoprim in clinically isolated gram-negative bacteria. Chemotherapy 25:147–156
GrunbergE., BeskidG.1977; Studies on the in vitro development of drug resistance of Porteeae to sulphonamides, trimethoprim and combinations of a sulphonamide and trimethoprim. Chemotherapy 23:309–313
GrünebergR. N.1972 The choice of treatment for urinary infections according to the sensitivities of the causative organisms. Advances in antimicrobial and antineoplastic chemotherapy1 edited by HejzlarM., SemonskyM., MasakS. Avicenum; Prague:749
GrünebergR. N.1975; The use of co-trimoxazole in sulphonamide-resistant Escherichia coli in urinary tract infection. Journal of Antimicrobial Chemotherapy 1:305–310
GrünebergR. N.1979; The microbiological rationale for the combination of sulphonamides and trimethoprim. Journal of Antimicrobial Chemotherapy 5:suppl. B27–36
GuerrantR. L., WoodS. J., KrongaardL., ReidR. A., HodgeR. H.1981; Resistance among fecal flora of patients taking sulphamethoxazole-trimethoprim or trimethoprim alone. Antimicrobial Agents and Chemotherapy 19:33–38
Hamilton-MillerJ. M. T.1979; Mechanisms and distribution of bacterial resistance to diaminopyrimidines and sulphonamides. Journal of Antimicrobial Chemotherapy 5:suppl. B61–73
HansenI., NeilsenM. L., HeerfordtL., HenriksenB. I., BertelsenS.1973; Trimethoprim in normal and pathological human lung tissue. Chemotherapy 19:221–234
HeffronF., RubensC., FalkowS.1975; Translocation of a plasmid DNA sequence which mediates ampicillin resistance: molecular nature and specificity of insertion. Proceedings of the National Academy of Sciences of the USA 72:3623–3627
HellingR. B., KinneyT., AdamsJ.1981; The maintenance of plasmid-containing organisms in populations of Escherichia coli. Journal of General Microbiology 123:129–141
HoigneR., MüllerU., SchneiderH. R.1970; A comparison of chemotherapy in patients with urinary tract infections using trimethoprim alone and in combination with sulphamethoxazole (gantanol). Proceedings of the 6th International congress of chemotherapyUniversity of Tokyo Press, Tokyo63
HowardA. J., HinceC. J., WilliamsJ. D.1978; Antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae. Report of study group on bacterial resistance. British Medical Journal 1:1657–1660
KasanenA. 7 others 1978; Trimethoprim. Pharmacology, antimicrobial activity and clinical use in urinary tract infections. Annals of Clinical Research 10:suppl. 221–39
KasanenA., KaarsaloE., HiltunenR., SoiniV.1974a; Comparison of long term, low-dosage nitrofurantoin, methenamine hippurate, trimethoprim and trimethoprim-sulphamethoxazole on the control of recurrent urinary tract infection. Annals of Clinical Research 6:285–289
KasanenA., ToivanenP., SouranderL., KaarsaloE., AantaaS.1974b; Trimethoprim in the treatment and long-term control of urinary tract infection. Scandinavian Journal of Infectious Diseases 6:91–96
KayserF. H., MullerI.1978; Resistance of bacteria to sulphamethoxazole/trimetho-prim. Current Chemotherapy edited by SiegenthalerW., LuthyR.Proceedings of the 10th International Congress of Chemotherapy1 American Society for Microbiology; Washington DC:657
KochU. J., SchumannK. P., KüchlerR., KewitzH.1973; Efficacy ot trimethoprim, sulphamethoxazole and the combination of both in acute urinary tract infection. Clinical and pharmacokinetical studies. Chemotherapy 19:314–321
KnotheH.1979; The effect of trimethoprim-sulphonamide, trimethoprim and sulphonamide on the occurrence of resistant Enterobacteriaceae in human intestinal flora. Infection 7:suppl. 4321–323
KuninC. M., CraigW. A., UehlingD. T.1978; Trimethoprim therapy for urinary tract infections. Long-term prophylaxis in a uremic patient. Journal of the American Medical Association 239:2588–2590
LaceyR. W.1969; Dwarf-colony variants of Staphylococcus aureus resistant to aminogluco-side antibiotics and to a fatty acid. Journal of Medical Microbiology 2:187–197
LaceyR. W.1979a; Mechanism of action of trimethoprim and sulphonamides: relevance to synergy in vivo. Journal of Antimicrobial Chemotherapy 5:suppl. B75–83
LaceyR. W.1979b Mechanism of antibiotic resistance in Staphylococcus aureus: with particular reference to the use of antibiotics in combinations. Combined antimicrobial therapy edited by BrumfittW., CurcioL., SilvestriL. Martinus Nijhaff; The Hague:15–27
LaceyR. W.1980; Evidence for two mechanisms of plasmid transfer in mixed cultures of Staphylococcus aureus. Journal of General Microbiology 119:423–435
LaceyR. W., LewisE., GrinstedJ.1973; Loss of antibiotic resistance in Staphylococcus aureus in vivo probably resulting from cloxacillin therapy. Journal of Medical Microbiology 6:191–199
LaceyR. W., LordV. L., GunasekeraH. K. W., LeibermannP. J., LuxtonD. E. A.1980a; Comparison of trimethoprim alone with trimethoprim sulphamethoxazole in the treatment of respiratory and urinary infections with particular reference to selection of trimethoprim resistance. Lancet 1:1270–1273
LaceyR. W., RogersonJ. G., StokesA.1980b; Antibacterial effects of trimethoprim and sulphadiazine in human urine and blood. Journal of Medical Microbiology 13:121–132
LaceyR. W. 6 others 1981; Comparison of single dose trimethoprim with a five day course for the treatment of urinary infections in the elderly. Age and Ageing 10:179–185
LewisE., LaceyR. W.1973; Present significance of resistance to trimethoprim and sulphonamides in coliforms, Staphylococcus aureus and Streptococcus faecalis. Journal of Clinical Pathology 26:175–180
LillyH. A., LowburyE. J. L.1978; Antibiotic resistance of Staphylococcus aureus in a burns unit after stopping routine prophylaxis with erythromycin. Journal of Antimicrobial Chemotherapy 4:545–550
LowburyE. J. L., BabbJ. R., RoeE.1972; Clearance from a hospital of gram-negative bacilli that transfer carbenicillin-resistance to Pseudomonas aeruginosa. Lancet 2:941–945
MabeckC. E., VejlsgaardR.1980; Treatment of urinary tract infections in general practice with sulphamethizole, trimethoprim or co-trimazine (sulphadiazine-trimetho-prim). Journal of Antimicrobial Chemotherapy 6:701–708
McCarthyL. R., ChmelH., BellG., ArmstrongD.1977; Thymine-dependent strain of Salmonella oslo selected by trimethoprim-sulfamethoxazole therapy. American Journal of Clinical Pathology 68:307–311
MannistoP. T.1976; Comparison of oxolinic acid, trimethoprim and trimethoprim-sulpha-methoxazole in the treatment and long-term control of urinary tract infection. Current Therapeutic Research 20:645–654
MoorhouseE. C., FarrellW.1973; Effect of co-trimoxazole on faecal enterobacteria; no emergence of resistant strains. Journal of Medical Microbiology 6:249–252
MosherR. A., DiRenzoA. B., MathewsC. K.1977; Bacteriophage T4 virion dihydrofolate reductase: approaches to quantitation and assessment of function. Journal of Virology 23:645–658
OkubadejoO. A., MaskellR. M.1973; Thymine-requiring mutants of Proteus mirabilis selected by co-trimoxazole in vivo. Journal of General Microbiology 77:533–535
PancoastS. J., HyamsD. M., NeuH.1980; Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal floras. Antimicrobial Agents and Chemotherapy 17:263–268
PattishallK. H., AcarJ., BurchallJ. J., GolsteinF. W., HarveyR. J.1977; Two distinct types of trimethoprim-resistant dihydrofolate reductase specified by R-plasmids of different compatibility groups. Journal of Biological Chemistry 252:2319–2323
PearsonN. J., TownerK. J., McSherryA. M., CattellW. R., O’GradyF.1979; Emergence of trimethoprim-resistant enterobacteria in patients receiving long-term co-trimoxazole for the control of intractable urinary tract infection. Lancet 2:1205–1209
SchnaarsP., EscherJ.1969; Results obtained in the treatment of acute and chronic urinary tract infections with co-trimoxazole or its components of sulphamethoxazole and trimethoprim. Praxis 58:1279–1283 in German
ShapiroJ. A., SpornP.1977; Tn 402: a new transposable element determining trimethoprim resistance that inserts into bacteriophage lambda. Journal of Bacteriology 129:1632–1635
SköldO., WidhA.1974; A new dihydrofolate reductase with low trimethoprim sensitivity induced by an R-factor mediating high resistance to trimethoprim. Journal of Biological Chemistry 249:4323–4325
SmellieJ. M., GrünebergR. N., LeakeyA., AtkinsW. S.1976; Long-term low-dose co-trimoxazole in prophylaxis of childhood urinary tract infection: clinical aspects. British Medical Journal 2:203–206
SouranderL., SaarimaaH., ArvilommiH.1972; Treatment of sulphonamide-resistant urinary tract infections with a combination of sulphonamide and trimethoprim. Acta Medica Scandinavica 191:1–3
StammW. E. 7 others 1980; Antimicrobial prophylaxis of recurrent urinary tract infections; a double blind, placebo controlled trial. Annals of Internal Medicine 92:770–775
StoneD., SmithS. L.1970; The amino acid sequence of the trimethoprim-resistant dihydrofolate reductase specified in Escherichia coli by R-plasmid R67. Journal of Biological Chemistry 254:10857–10861
Tennhammar-EkmanB., SköldO.1979; Trimethoprim resistant plasmids of different origin encode different drug-resistant dihydrofolate reductases. Plasmid 2:334–346
ThenR. L., RiggenbachH.1978; Dihydrofolate reductases in some folate-requiring bacteria with low trimethoprim susceptibility. Antimicrobial Agents and Chemotherapy 14:112–117
ToivanenA., KasanenA., SundquistH., ToivanenP.1976; Effect of trimethoprim on the occurrence of drug-resistant coliform bacteria in the faecal flora. Chemotherapy 22:97–103
TownerK. J.1979; Classification of transferable plasmids conferring resistance to trimethoprim isolated in Great Britain. FEMS Microbiology Letters 5:319
TownerK.J.1981; A clinical isolate oî Escherichia coli owing its trimethoprim resistance to a chromosomally-located trimethoprim transposon. Journal of Antimicrobial Chemotherapy 1:157–162
TownerK. J., PearsonN. J., PinnP. A., O’GradyF.1980; Increasing importance of plasmid-mediated trimethoprim resistance in enterobacteria: two six-month clinical surveys. British Medical Journal 280:517–519
Trimethoprim study group1981; Comparison of trimethoprim at three dosage levels with co-trimoxazole in the treatment of acute symptomatic urinary tract infection in general practice. Journal of Antimicrobial Chemotherapy 1:179–183
WeisblumB.1971 Macrolide resistance in Staphylococcus aureus. Macrolide antibiotics and lincomycin edited by MitsuhashiS. University Park Press; Baltimore: